PCSK9 inhibitors: Going forward and beyond

被引:1
作者
Attar, Armin [1 ]
机构
[1] Shiraz Univ Med Sci, Dept Cardiovasc Med, TAHA Clin Trial Grp, Shiraz, Iran
关键词
LDL-CHOLESTEROL; SECONDARY ANALYSIS; CLINICAL-EFFICACY; EVOLOCUMAB; SAFETY; STATIN;
D O I
10.1177/2047487320916964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:803 / 804
页数:2
相关论文
共 13 条
[1]   Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].
Abifadel, M ;
Varret, M ;
Rabès, JP ;
Allard, D ;
Ouguerram, K ;
Devillers, M ;
Cruaud, C ;
Benjannet, S ;
Wickham, L ;
Erlich, D ;
Derré, A ;
Villéger, L ;
Farnier, M ;
Beucler, I ;
Bruckert, E ;
Chambaz, J ;
Chanu, B ;
Lecerf, JM ;
Luc, G ;
Moulin, P ;
Weissenbach, J ;
Prat, A ;
Krempf, M ;
Junien, C ;
Seidah, NG ;
Boileau, C .
NATURE GENETICS, 2003, 34 (02) :154-156
[2]   Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial [J].
Fitzgerald, Kevin ;
Frank-Kamenetsky, Maria ;
Shulga-Morskaya, Svetlana ;
Liebow, Abigail ;
Bettencourt, Brian R. ;
Sutherland, Jessica E. ;
Hutabarat, Renta M. ;
Clausen, Valerie A. ;
Karsten, Verena ;
Cehelsky, Jeffrey ;
Nochur, Saraswathy V. ;
Kotelianski, Victor ;
Horton, Jay ;
Mant, Timothy ;
Chiesa, Joseph ;
Ritter, James ;
Munisamy, Malathy ;
Vaishnaw, Akshay K. ;
Gollob, Jared A. ;
Simon, Amy .
LANCET, 2014, 383 (9911) :60-68
[3]   Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial [J].
Giugliano, Robert P. ;
Keech, Anthony ;
Murphy, Sabina A. ;
Huber, Kurt ;
Tokgozoglu, S. Lale ;
Lewis, Basil S. ;
Ferreira, Jorge ;
Pineda, Armando Lira ;
Somaratne, Ransi ;
Sever, Peter S. ;
Pedersen, Terje R. ;
Sabatine, Marc S. .
JAMA CARDIOLOGY, 2017, 2 (12) :1385-1391
[4]   Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial [J].
Giugliano, Robert P. ;
Pedersen, Terje R. ;
Park, Jeong-Gun ;
De Ferrari, Gaetano M. ;
Gaciong, Zbigniew A. ;
Ceska, Richard ;
Toth, Kalman ;
Gouni-Berthold, Ioanna ;
Lopez-Miranda, Jose ;
Schiele, Francois ;
Mach, Francois ;
Ott, Brian R. ;
Kanevsky, Estelle ;
Pineda, Armando Lira ;
Somaratne, Ransi ;
Wasserman, Scott M. ;
Keech, Anthony C. ;
Sever, Peter S. ;
Sabatine, Marc S. .
LANCET, 2017, 390 (10106) :1962-1971
[5]   2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk [J].
Mach, Francois ;
Baigent, Colin ;
Catapano, Alberico L. ;
Koskina, Konstantinos C. ;
Casula, Manuela ;
Badimon, Lina ;
Chapman, M. John ;
De Backer, Guy G. ;
Delgado, Victoria ;
Ference, Brian A. ;
Graham, Ian M. ;
Halliday, Alison ;
Landmesser, Ulf ;
Mihaylova, Borislava ;
Pedersen, Terje R. ;
Riccardi, Gabriele ;
Richter, Dimitrios J. ;
Sabatine, Marc S. ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale ;
Wiklund, Olov ;
Windecker, Stephan ;
Aboyans, Victor ;
Baigent, Colin ;
Collet, Jean-Philippe ;
Dean, Veronica ;
Delgado, Victoria ;
Fitzsimons, Donna ;
Gale, Chris P. ;
Grobbee, Diederick ;
Halvorsen, Sigrun ;
Hindricks, Gerhard ;
Iung, Bernard ;
Juni, Peter ;
Katus, Hugo A. ;
Leclercq, Christophe ;
Lettino, Maddalena ;
Lewis, Basil S. ;
Merkely, Bela ;
Mueller, Christian ;
Petersen, Steffen ;
Petronio, Anna Sonia ;
Roffi, Marco ;
Shlyakhto, Evgeny ;
Simpson, Iain A. ;
Sousa-Uva, Miguel ;
Touyz, Rhian M. ;
Nibouche, Djamaleddine ;
Zelveian, Parounak H. ;
Siostrzonek, Peter .
ATHEROSCLEROSIS, 2019, 290 :140-205
[6]   Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial [J].
Robinson, Jennifer G. ;
Nedergaard, Bettina S. ;
Rogers, William J. ;
Fialkow, Jonathan ;
Neutel, Joel M. ;
Ramstad, David ;
Somaratne, Ransi ;
Legg, Jason C. ;
Nelson, Patric ;
Scott, Rob ;
Wasserman, Scott M. ;
Weiss, Robert .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (18) :1870-1882
[7]  
Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]
[8]   Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events [J].
Sabatine, Marc S. ;
Giugliano, Robert P. ;
Wiviott, Stephen D. ;
Raal, Frederick J. ;
Blom, Dirk J. ;
Robinson, Jennifer ;
Ballantyne, Christie M. ;
Somaratne, Ransi ;
Legg, Jason ;
Wasserman, Scott M. ;
Scott, Robert ;
Koren, Michael J. ;
Stein, Evan A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (16) :1500-1509
[9]   Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome [J].
Schwartz, G. G. ;
Steg, P. G. ;
Szarek, M. ;
Bhatt, D. L. ;
Bittner, V. A. ;
Diaz, R. ;
Edelberg, J. M. ;
Goodman, S. G. ;
Hanotin, C. ;
Harrington, R. A. ;
Jukema, J. W. ;
Lecorps, G. ;
Mahaffey, K. W. ;
Moryusef, A. ;
Pordy, R. ;
Quintero, K. ;
Roe, M. T. ;
Sasiela, W. J. ;
Tamby, J. -F. ;
Tricoci, P. ;
White, H. D. ;
Zeiher, A. M. ;
Aylward, Philip E. ;
Drexel, Heinz ;
Sinnaeve, Peter ;
Dilic, Mirza ;
Lopes, Renato D. ;
Gotcheva, Nina N. ;
Goodman, Shaun G. ;
Prieto, Juan-Carlos ;
Yong, Huo ;
Lopez-Jaramillo, Patricio ;
Pecin, Ivan ;
Reiner, Zeljko ;
Ostadal, Petr ;
Poulsen, Steen Hvitfeldt ;
Viigimaa, Margus ;
Nieminen, Markku S. ;
Danchin, Nicolas ;
Chumburidze, Vakhtang ;
Marx, Nikolaus ;
Liberopoulos, Evangelos ;
Montenegro Valdovinos, Pablo Carlos ;
Tse, Hung-Fat ;
Kiss, Robert Gabor ;
Xavier, Denis ;
Zahger, Doron ;
Valgimigli, Marco ;
Kimura, Takeshi ;
Kim, Hyo Soo .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22) :2097-2107
[10]   LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial [J].
Sever, Peter ;
Gouni-Berthold, Ioanna ;
Keech, Anthony ;
Giugliano, Robert ;
Pedersen, Terje R. ;
Im, KyungAh ;
Wang, Huei ;
Knusel, Beat ;
Sabatine, Marc S. ;
O'Donoghue, Michelle L. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (08) :805-812